what is the bmi requirement for semaglutide GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis FDA-Approved Semaglutide: BMI to Qualify

Sikiric, P., Udovicic, M., Barisic, I., Balenovic, D., Zivanovic Posilovic, G., Strinic, D., Uzun, S., Sikiric, S., Krezic, I., Zizek, H., Yago, H., Gojkovic, S., Smoday, I

Weight loss alone does not disqualify you

Strength and Structure Matter Here GLP-1 medications are tools

Supplementation should always be integrated into a broader protocol that includes aggressive pacing to manage post-exertional malaise, careful symptom tracking, dietary modifications to support histamine clearance, and ongoing medical care from specialists who truly understand the interconnected nature of neuro-immune diseases

If you are on medications, pregnant or nursing a baby, consult a health care practitioner prior to taking

As part of the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) program, the efficacy of once-weekly subcutaneous semaglutide was evaluated in over 7,000 patients in six global phase IIIa trials (SUSTAIN 16) across the wide spectrum of the T2D disease course ( Table 1 )